Get in touch
CEPI is keen to discuss potential involvement with governments, funders, industry partners, academia, regulators, civil society organisations, and vaccine research groups. Please fill out the contact form below to get in touch with us.
Contact us
Get in touch
Press enquiries
If you have a press enquiry, please complete the contact form or email us directly at:
Speaker requests
To request the participation of a CEPI spokesperson at an event, please complete the following form:
Download and complete our Speaker request form(DOCX, 35.8 KB)
Send the completed form to [email protected]
Completed forms should be sent to [email protected]
A member of the CEPI team will review your request and if we are able to provide you with a relevant spokesperson we will be in touch to make further arrangements. Please note, CEPI receives a large volume of enquiries and whilst we always endeavour to fulfil speaker requests this won’t be possible on every occasion.
Latest News
Latest News
New project aims to bolster global vaccine preparedness against SARS-CoV-1 and SARS-CoV-2
Project will help to ensure the availability of antibody reagents for the development of vaccines against SARS-CoV-1 and SARS-CoV-2.
New study to assess mpox vaccine in pregnant women and infants
The research could help expand vaccine access to these populations at risk of mpox complications but not currently eligible for vaccination.
The Caliciviruses, Reoviruses and Astroviruses
Attackers from these three viral families cause hundreds of millions of cases of severe diarrhoea and vomiting every year - many of them deadly.
Immune-boosting bacterial platform could aid nasal vaccines
Researchers at Abera Bioscience are set to test whether their bacterial-based platform could strengthen intranasal vaccines being developed to protect against epidemic and pandemic threats.
100 days to save eight million lives
Deploying effective COVID-19 vaccines in 100 days could have saved over eight million lives.
Canadian scientists to optimise vaccine process for faster outbreak response
Researchers will investigate whether they can speed up the creation of key vaccine ingredients to respond more quickly to future threats.
Promising human Rift Valley fever vaccine to enter Phase II clinical trials in Kenya
New CEPI-funded trial to launch in Kenya – the first ever Phase II trial of a Rift Valley fever vaccine in an endemic country mary text here
World-leading Coronavirus vaccine R&D roadmap to receive fresh updates
An important tool created to guide the development of vaccines against multiple potentially deadly Coronaviruses is being expanded.
New vaccine-making process could transform pandemic response
Scientists will receive CEPI funding to advance the RNAbox™, a process designed to scale production of mRNA vaccines at regional manufacturing sites.
Marburg – What it is, and what it is not
What is Marburg virus? How does it spread? Is there a cure? CEPI answers some of the most frequently asked online questions about this virus.
Latest News
Our locations
Oslo, Norway (HQ)
Visiting:
Skøyen Atrium, Askekroken 11, 0277 Oslo
Postal:
Postbox 1030 Hoff, 0218 Oslo
London, UK
CEPI, 6th floor, Henry Wood House, 4-5 Langham Place, London, W1B 3DG
Washington, USA
1901 Pennsylvania Ave, NW; Suite 1003; Washington, DC 20006; USA